NanoSynex Ltd.

Nanosynex is an Israeli MedTech startup created in 2017 that aims at providing new solutions to improve testing quality and reduce healthcare costs by speeding up diagnostic processes.

Today, Nanosynex is focused on the development and commercialization of an innovative Antimicrobial Susceptibility Test (AST). The technology is based on a purely phenotypic approach and uses a microfluidic disposable test cartridge platform and method that optimizes bacterial growth. This disruptive development was born from exciting research discoveries at the lab of Professor Shulamit Levenberg, Dean of the Technion Biomedical Engineering Faculty.